FDA staff review recommends against Novartis heart failure drug
WASHINGTON (Reuters) - A drug to treat acute heart failure made by Novartis AG should not be approved because there is insufficient evidence to show i...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Dg1Y-Op7heQ/story01.htm
No comments:
Post a Comment